Ginkgo Biloba
Best-in-class: Ginkgo Biloba
One of the most-studied herbs for cognition, improving cerebral blood flow and offering antioxidant support for memory and mental sharpness.
Ginkgo Biloba quick facts
| Suggested dose | 120–240 mg standardized extract (EGb 761-type) daily. |
| How often | Daily |
| Who it's for | Memory and circulation support, especially with age. |
The GEM trial randomized over 3,000 older adults and found it does not prevent dementia — that result is real and should not be soft-pedalled. It says nothing about acute cognitive effects in healthy adults, which is a different question with more equivocal but not negative evidence. The antiplatelet activity is clinically meaningful: combined with aspirin, warfarin or fish oil it raises bleeding risk, and it needs stopping before surgery.
How Ginkgo Biloba actually works
Flavone glycosides and terpene lactones acting on two fronts: improved microcirculation through vasodilation and reduced blood viscosity, and platelet-activating factor antagonism, which is where the antiplatelet effect and part of the anti-inflammatory action come from. It also has direct antioxidant activity in neural tissue.
Where to get Ginkgo Biloba
Find Ginkgo Biloba on iHerb →The evidence for Ginkgo Biloba
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs/meta-analyses show benefit for memory and cognition, especially in older adults and vascular cognitive issues.
- Improves microcirculation and has antioxidant effects.
📊 Correlative data
- Cognitive decline tracks with reduced cerebral blood flow that ginkgo supports.
🧪 Theoretical / extrapolated benefits
- Broad neuroprotection claims are plausible; effects are modest and best in older/vascular populations.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Ginkgo Biloba actually does
EGb 761 is not a plant, it is a specification. The extract that carries almost every ginkgo trial is defined by three numbers: 22–27% flavone glycosides, 5–7% terpene lactones, and ginkgolic acids held below 5 parts per million. Those two fractions are credited with completely different things, and a label that prints “Ginkgo 120 mg” has told you which plant and nothing about either number.
The terpene lactones are the pharmacology. This fraction is ginkgolides A, B, C and J plus bilobalide — cage-shaped diterpenes found nowhere else in the plant kingdom. Ginkgolide B is a competitive antagonist at the platelet-activating factor receptor, a G protein-coupled receptor on platelets, neutrophils and endothelium. That single fact explains why this herb turns up in bleeding case reports and why its most reliably detectable effect in a healthy person is not cognitive Mai 2025. Bilobalide is the fraction credited with the mitochondrial and neuroprotective work.
The flavone glycosides are not what gets absorbed. Quercetin, kaempferol and isorhamnetin leave the leaf attached to sugars. Those glycosides are poor substrates for absorption; they are deglycosylated — by brush-border lactase-phlorizin hydrolase and by bacterial beta-glucosidases in the colon — and what reaches plasma is the aglycone and its glucuronide and sulfate conjugates. So the number the label standardizes on describes the capsule, not the bloodstream, and the conversion step sits in a microbiome that differs between people.
And there is a third molecule nobody sells but everybody swallows. Ginkgo tissue contains 4'-O-methylpyridoxine, called ginkgotoxin. It is an alternate substrate of human pyridoxal kinase — and it binds with a lower Km than pyridoxal, pyridoxamine or pyridoxine themselves, so it out-competes the vitamin for its own activating enzyme and temporarily lowers pyridoxal 5'-phosphate formation Kastner 2007. Pyridoxal phosphate is the cofactor glutamate decarboxylase needs to make GABA. A candidate mechanism for the seizure signal on this herb therefore exists, it is enzymatic, and it has nothing to do with the flavonoids on the label.
Cell, rodent, human — and where it stops
Enzyme, then fish, then a person — for the toxin half, the chain is complete. Recombinant human pyridoxal kinase, ginkgotoxin as a competing substrate Kastner 2007. Zebrafish larvae exposed for 2 hours develop seizure-like behavior that is relieved by pyridoxal 5'-phosphate, by GABA, and by gabapentin and phenytoin Lee 2012. A 51-year-old woman ate a large quantity of ginkgo nuts, had a generalized tonic-clonic seizure with a low blood vitamin B6, and recovered completely on pyridoxine Jang 2015. Cell to animal to human, on the harm.
For the benefit half, the chain ends in two of the largest supplement trials ever funded, and both are null. The Ginkgo Evaluation of Memory study randomized 3,069 people aged 72–96 to 120 mg of extract twice daily or placebo and followed them for a median of 6.1 years. Dementia developed in 523: 277 on ginkgo and 246 on placebo, hazard ratio 1.12, p = 0.21 DeKosky 2008. The cognitive read-out from the same cohort found no difference in the annual rate of decline in memory, attention, visuospatial ability, language or executive function Snitz 2009.
GuidAge randomized 2,854 people aged 70 and over who had come to a doctor with a memory complaint — the enriched population everyone said the GEM study lacked — to the same 120 mg twice daily for 5 years. Probable Alzheimer's disease occurred in 61 on ginkgo against 73 on placebo, hazard ratio 0.84, p = 0.306 Vellas 2012.
Now the obstacle, and it is the reverse of the usual one. Normally the complaint is that the trial was in sick people and you are well. Here the trials were in exactly the population the marketing points at — older adults, memory complaints, vascular risk — they ran for five and six years at a dose at the top of the label range, and they found nothing. The healthy 35-year-old buying this for focus is not merely outside the evidence; he is outside evidence that already failed in the group most likely to respond.
Ginkgo Biloba — which form, and does it matter
The gap between the drug and the supplement has been measured, and it is not a rumor. An analysis of 63 ginkgo preparations sold in Germany compared products approved as drugs against products sold as food supplements. The approved drugs were pharmaceutically reliable; the dietary supplements were of dubious reliability, which is the authors' phrase, and the paper's conclusion questions whether the food-industry products can deliver a health benefit at all Trabert 2023. Germany is the country where this extract was developed and where regulation is tightest.
What the specification buys you, in milligrams. At the standardized 24% and 6%, a 120 mg capsule of genuine EGb 761-type extract carries about 28.8 mg of flavone glycosides and 7.2 mg of terpene lactones. Dried ginkgo leaf carries these constituents at roughly a fiftieth of that concentration, which is what the 50:1 concentration ratio of the extract means in practice. A capsule labeled “ginkgo leaf 120 mg” with no ratio and no percentages is therefore not a slightly weaker version of the trial material; on the terpene lactones it is delivering a small fraction of the tested amount, and the label gives you no way to work out which fraction.
The ceiling nobody prints. Ginkgolic acids are the allergenic, cytotoxic alkylphenols of the plant, and the drug specification caps them below 5 ppm. No such cap binds a food supplement, and the German survey is the closest anyone has come to asking whether it matters Trabert 2023. If you buy one number off a ginkgo label, buy this one.
Phytosomes and complexes are a third category. Where a product declares a ginkgo-phospholipid complex by the weight of the complex, the extract inside it is a fraction of that weight and the flavone glycoside content is unstated. It is not comparable, milligram for milligram, to the 120 mg used in the trials.
What would have to be true, and how you would know it was not
1. The cognitive prediction, and it is a prediction of nothing. Take a validated instrument twice — Trail Making A and B plus a 15-word list with delayed recall — at day 0 and at week 12, on 240 mg a day of standardized extract. Predict no change beyond the practice effect, because two trials totaling 5,923 people found no change in any cognitive domain over five and six years Snitz 2009 Vellas 2012. The practice effect is what will fool you: everybody scores better the second time they see a Trail Making sheet, and that improvement is worth roughly as much as the capsule.
2. The prediction that cuts against the product, and it is the one that will actually come true. If ginkgolide B is antagonizing the platelet-activating factor receptor at a label dose, the detectable effect is hemostatic rather than cognitive. Predict a longer bruise, the odd nosebleed, and on a platelet function assay a measurably longer closure time within 4 weeks. Predict, in other words, that the only thing you can reliably detect from this herb is the reason to stop it before surgery Mai 2025.
3. A pyridoxal-phosphate prediction nobody has tested. If a leaf preparation carries meaningful ginkgotoxin, chronic use should bend plasma pyridoxal 5'-phosphate downward, because the toxin competes for the kinase that activates B6 Kastner 2007. Plasma PLP is an orderable test. Predict a fall of less than 10% on a properly specified extract and no fall at all on a drug-grade product — and treat a clear drop as information about your bottle rather than about ginkgo.
What would change the verdict: a 12-week randomized trial in healthy adults under 60 showing a Trail Making B improvement larger than the alternate-form practice effect. That trial does not exist.
What nobody has tested yet
Nobody has run a drug-grade extract against a supermarket one, head to head, with the assays in the protocol. The German survey established that the two categories differ chemically Trabert 2023; no trial has ever randomized people to the two categories and measured anything. Every argument about ginkgo quality is currently an argument about a certificate of analysis rather than about an outcome.
Nobody has measured plasma 4'-O-methylpyridoxine in chronic users of leaf extract. The enzymology is settled Kastner 2007 and the seizure phenotype is reproducible in a vertebrate Lee 2012, but the exposure question — how much ginkgotoxin is in a daily capsule of standardized leaf extract, and where does it put plasma PLP after six months — is a mass spectrometry run and a blood draw, and it has not been published.
Nobody has stratified a ginkgo trial by the microbiome that activates it. If flavone glycosides need bacterial beta-glucosidase before they can be absorbed, then gut flora is a dose modifier, and the obvious source of responder variation in a 3,069-person null trial has never been looked at DeKosky 2008.
And nobody has separated the two fractions in a human. The terpene lactones and the flavone glycosides are credited with different actions and have never been given separately to people with a shared endpoint. A three-arm trial — whole extract, terpene-depleted extract, flavone-depleted extract — would settle in one study which half, if either, is worth standardizing.
Ginkgo Biloba — its own safety story, not its category's
The bleeding interaction is pharmacodynamic, and it has now been counted. In an analysis of 2,647 prescriptions, 342 — 12.94% — involved a ginkgo drug interaction; clopidogrel and aspirin were the most frequent partners at 2.61% each. Among 747 patients examined for bleeding, 31, or 4.15%, had bleeding symptoms, and drug interactions were associated with bleeding risk with an odds ratio of 1.08 and with abnormal coagulation at an odds ratio of 1.49, both p < 0.001 Mai 2025. The odds ratios are modest; the point is that the interaction is real, measurable and invisible on a drug level, because ginkgo does not change how much warfarin you have — it changes what your platelets do about it.
Two weeks before surgery, and volunteer it. Surgeons and anesthetists ask about prescription anticoagulants and rarely about a herb. Given a platelet-activating-factor antagonist with a several-day tissue presence, two weeks is the conventional and sensible margin, and stopping is on you to remember.
The seizure question deserves a mechanism rather than a warning. Ginkgotoxin competes with pyridoxal for pyridoxal kinase Kastner 2007; the result in a whole organism is seizure-like activity rescued by pyridoxal 5'-phosphate Lee 2012; and the human case that closes the loop was a seizure with a low B6 after eating ginkgo nuts, which resolved on pyridoxine Jang 2015. The concentration is far higher in seed than in leaf, which is why the practical rule is that ginkgo nuts are food with a dose limit and raw ones are not food at all. If you have epilepsy, this is not the herb to experiment with.
Who should not take it: anyone on warfarin, apixaban, rivaroxaban, clopidogrel or daily aspirin; anyone with a bleeding disorder or a scheduled procedure; anyone with epilepsy or on a seizure-threshold-lowering drug; and anyone who would be taking it instead of investigating a memory complaint, because a memory complaint in an older adult is a reason to be assessed rather than a reason to buy a supplement that failed this endpoint twice DeKosky 2008 Vellas 2012.
Sources read for this page
- DeKosky ST, Williamson JD, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008 · PMID 19017911
- Snitz BE, O'Meara ES, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009 · PMID 20040554
- Vellas B, Coley N, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurology 2012 · PMID 22959217
- Trabert M, et al. Critical analysis of ginkgo preparations: comparison of approved drugs and dietary supplements marketed in Germany. Naunyn-Schmiedeberg's Archives of Pharmacology 2023 · PMID 37470803
- Mai NTQ, et al. Impact of Ginkgo biloba drug interactions on bleeding risk and coagulation profiles: A comprehensive analysis. PLoS One 2025 · PMID 40198642
- Kastner U, et al. The human pyridoxal kinase, a plausible target for ginkgotoxin from Ginkgo biloba. FEBS Journal 2007 · PMID 17250738
- Lee GH, et al. Zebrafish larvae exposed to ginkgotoxin exhibit seizure-like behavior that is relieved by pyridoxal-5'-phosphate, GABA and anti-epileptic drugs. Disease Models & Mechanisms 2012 · PMID 22736461
- Jang HS, et al. Ginkgotoxin Induced Seizure Caused by Vitamin B6 Deficiency. Journal of Epilepsy Research 2015 · PMID 26819944
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Word-finding and name recall in conversation, counted rather than felt — how many times in a week you reach for a word and it does not come. Ginkgo's benefit is clearest in older adults and in vascular cognitive problems, so in a healthy thirty-year-old the honest expectation is nothing.
- How long before it means anything: Twelve weeks at a standardized extract dose. Its trials run long and the cerebral circulation mechanism it works through is not a same-week effect in anybody.
- What will fool you: Being in the wrong population, which is where most disappointment with this herb comes from — the evidence is about who is taking it at least as much as how much. The blood-thinning effect outweighs the whole question if you are on an anticoagulant or have surgery coming.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Ginkgo Biloba — safety & side effects
- Headache, dizziness and GI upset early on.
- Additive bleeding risk with anticoagulants and antiplatelets — warfarin, apixaban, rivaroxaban, clopidogrel, and aspirin at any dose. The interaction is pharmacodynamic rather than metabolic, so it does not show up as a changed drug level; it shows up as bruising, nosebleeds or a raised INR. Ginkgo is the classic example — spontaneous bleeding, including intracranial, has been reported alongside aspirin and warfarin.
- Lowers the seizure threshold — avoid with epilepsy. Never consume raw ginkgo seeds, which are toxic.
The same on every page it applies to. Read it here; it is not repeated research.
- Stop at least two weeks before any surgery or dental extraction. Surgeons ask about prescription blood thinners and rarely about supplements, so this one is on you to volunteer.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Ginkgo Biloba in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Ginkgo Biloba
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Ginkgo Biloba — frequently asked questions
What is Ginkgo Biloba?
One of the most-studied herbs for cognition, improving cerebral blood flow and offering antioxidant support for memory and mental sharpness.
What is the suggested dose of Ginkgo Biloba?
120–240 mg standardized extract (EGb 761-type) daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Ginkgo Biloba dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Ginkgo Biloba?
Coach Cam sources Ginkgo Biloba from vetted, top-rated brands on iHerb — use the buy link on this page.
Ginkgo Biloba inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Ginkgo Biloba is used for
Ginkgo Biloba appears under 1 goal in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Ginkgo Biloba is the cerebral metabolism arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.